Stuart Tomc - CV Sciences VP Nutrition
| CVSI Stock | USD 0.04 0 11.11% |
Insider
Stuart Tomc is VP Nutrition of CV Sciences
| Phone | 866 290 2157 |
| Web | https://www.cvsciences.com |
CV Sciences Management Efficiency
The company has return on total asset (ROA) of (0.5182) % which means that it has lost $0.5182 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.36) %, meaning that it created substantial loss on money invested by shareholders. CV Sciences' management efficiency ratios could be used to measure how well CV Sciences manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Perry Antelman | Charlottes Web Holdings | 59 | |
| Stephen Rogers | Charlottes Web Holdings | 57 | |
| Tim Orr | Charlottes Web Holdings | N/A | |
| Howard Schacter | Marimed | N/A | |
| Timothy Shaw | Marimed | 45 | |
| Jared Stanley | Charlottes Web Holdings | 35 | |
| Kelly Shea | Charlottes Web Holdings | N/A | |
| Greg Gould | Charlottes Web Holdings | N/A | |
| Cory Pala | Charlottes Web Holdings | N/A | |
| Susan CPA | Marimed | 55 | |
| Jon Levine | Marimed | 58 | |
| Steve West | Marimed | N/A | |
| Robert Fireman | Marimed | 74 | |
| Richard Mohr | Charlottes Web Holdings | 63 | |
| Jonathan Rider | Marimed | 58 | |
| Sara Gullickson | Marimed | 38 | |
| Jacques Tortoroli | Charlottes Web Holdings | 64 | |
| Ryan Crandall | Marimed | N/A | |
| Charles Finnie | Marimed | N/A | |
| Andres Gortari | Charlottes Web Holdings | 47 | |
Management Performance
| Return On Equity | -2.36 | |||
| Return On Asset | -0.52 |
CV Sciences Leadership Team
Elected by the shareholders, the CV Sciences' board of directors comprises two types of representatives: CV Sciences inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVSI. The board's role is to monitor CV Sciences' management team and ensure that shareholders' interests are well served. CV Sciences' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CV Sciences' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Joseph Dowling, S CEO | ||
| Tim Hitchman, VP Operations | ||
| Jesse Karagianes, VP Growth | ||
| Joerg Grasser, Chief Officer | ||
| Stuart Tomc, VP Nutrition | ||
| Alyssa Dunn, Operations Mang |
CVSI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is CV Sciences a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -2.36 | |||
| Return On Asset | -0.52 | |||
| Profit Margin | (0.85) % | |||
| Operating Margin | (0.93) % | |||
| Current Valuation | 5.53 M | |||
| Shares Outstanding | 150.1 M | |||
| Shares Owned By Insiders | 2.01 % | |||
| Price To Earning | 54.89 X | |||
| Price To Book | 3.57 X | |||
| Price To Sales | 0.28 X |
Currently Active Assets on Macroaxis
Other Information on Investing in CVSI OTC Stock
CV Sciences financial ratios help investors to determine whether CVSI OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CVSI with respect to the benefits of owning CV Sciences security.